Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
AVAILABLE
NCT06362590
Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
Sponsor: Seagen Inc.
View on ClinicalTrials.gov
Summary
The purpose of this study is to provide the option of Ladiratuzumab Vedotin treatment to eligible patients in studies SGNLVA-005.
Key Details
Gender
Not specified
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-09-08
Healthy Volunteers
Not specified
Interventions
DRUG
ladiratuzumab vedotin